Aims & Scope

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal.

The journal provides the international community with a platform for the dissemination and study of clinical, translational, and basic research findings in this rapidly developing field.

Primary liver tumors, primarily hepatocellular carcinoma (HCC), are the third leading cause of cancer death worldwide, with around 750,000 new cases annually, and around 700,000 deaths.

While 80% occurs in the developing world, the incidence is beginning to decline due to hepatitis B vaccination and developments in food hygiene; conversely, there is an increasing incidence in the developed world, partly due to metabolic syndrome, obesity and diabetes.

The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.

Meta-analyses will no longer be considered for publication.

Specific topics covered by the journal include: • cell signalling pathways • molecular tumor classification and prognostication • new drugs and other therapies • new radiology approaches • epidemiology, surveillance, and prevention • psychosocial aspects and quality of life issues

View Aims & Scope

Metrics & Ranking

Journal Rank

Year Value
2024 7630

Journal Citation Indicator

Year Value
2024 524

Impact Factor

Year Value
2024 4.20

SJR (SCImago Journal Rank)

Year Value
2024 0.734

Quartile

Year Value
2024 Q2

h-index

Year Value
2024 10

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,650.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.


Quick Facts

Current Factor
4.20
First Published: 2024

SJR (SCImago Journal Rank)

SJR
0.734
First Published: 2024

Quartile

Current Quartile
Q2
First Published: 2024

Similar Journals

Top Journals in Related Fields